Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.30p
   
  • Change Today:
    -0.20p
  • 52 Week High: 17.60p
  • 52 Week Low: 1.50p
  • Currency: UK Pounds
  • Shares Issued: 623.91m
  • Volume: 1,239,337
  • Market Cap: £26.83m
  • RiskGrade: 328
  • Beta: 0.01

Regulatory News

Thermo Fisher CDMO selected for Kapiglucagon pro 22-Jul-2026 07:00 RNS
2026 RESULT OF ANNUAL GENERAL MEETING 25-Jun-2026 13:20 RNS
ImmuPharma appoints Bachem for Kapiglucagon API 25-Jun-2026 07:00 RNS
Notice of AGM & Annual Report & Accounts 02-Jun-2026 07:00 RNS
Final Results 27-May-2026 07:00 RNS
IMM initiatesIND-Enabling Program for Kapiglucagon 05-May-2026 07:00 RNS
Holding(s) in Company 10-Apr-2026 07:00 RNS
Result of General Meeting and TVR 07-Apr-2026 11:45 RNS
P140 Program Update 27-Mar-2026 07:00 RNS
Result of WRAP Retail Offer and TVR 23-Mar-2026 07:00 RNS
Publication of Circular 19-Mar-2026 09:00 RNS
WRAP Retail Offer for up to £1.5 million 17-Mar-2026 07:01 RNS
P140 Update; Fundraise, Related Party Transaction 17-Mar-2026 07:00 RNS
WRAP Retail Offer for up to £1.5 million 17-Mar-2026 07:01 RNS
P140 Update; Fundraise, Related Party Transaction 17-Mar-2026 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 4.30p
Change Today -0.20p
% Change -4.44 %
52 Week High 17.60p
52 Week Low 1.50p
Volume 1,239,337
Shares Issued 623.91m
Market Cap £26.83m
Beta 0.01
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 27-Jul-2026

Time Volume / Share Price
16:35 34 @ 4.30p
16:35 23 @ 4.30p
16:35 11 @ 4.30p
16:28 28,477 @ 3.94p
16:28 238 @ 3.90p

Immupharma Key Personnel

CFO Ashley Clarke

Top of Page